Outcome of Subclassification of Indeterminate (Thy-3) Thyroid Cytology into Thy-3a and Thy-3f

被引:18
|
作者
Brophy, Catherine [1 ]
Mehanna, Rania [1 ]
McCarthy, Julie [3 ]
Tuthill, Antoinette [4 ]
Murphy, Matthew S. [2 ]
Sheahan, Patrick [1 ]
机构
[1] South Infirm Victoria Univ Hosp, Dept Otolaryngol Head & Neck Surg, Cork, Ireland
[2] South Infirm Victoria Univ Hosp, Dept Endocrinol, Cork, Ireland
[3] Cork Univ Hosp, Dept Cytopathol, Cork, Ireland
[4] Cork Univ Hosp, Dept Endocrinol, Cork, Ireland
关键词
Thyroid; Cytology; Thy-3; Thy; Follicular lesion of uncertain significance; Atypia of uncertain significance;
D O I
10.1159/000441221
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The British Thy system is a widely used classification system for reporting thyroid fine-needle aspiration (FNA) cytology. The Royal College of Pathologists in 2009 recommended the subdivision of the Thy-3 (indeterminate) category into Thy-3a (atypia) and Thy-3f (follicular neoplasm). Our objective was to examine the malignancy rates of Thy-3a and Thy-3f cases at our institution and to investigate whether the risk of malignancy in Thy-3a cases is reduced by FNA on a different occasion showing benign cytology. Methods: This is a retrospective study of 748 thyroid nodules undergoing 1,032 FNAs, with indeterminate (Thy-3) cytology subdivided into Thy-3a and Thy-3f. Cases were correlated with final histology in surgical cases. Incidental carcinomas occurring outside the biopsied nodule were discounted. Results: A total of 109 nodules had a final cytological diagnosis of Thy-3a, of which 67 underwent surgery, with an incidence of malignancy of 13.4% (9/67); 90 nodules had a final cytological diagnosis of Thy-3f, of which 84 underwent surgery, with an incidence of malignancy of 17.9% (15/84). The difference in malignancy rates was not significant (p = 0.51). The incidence of malignancy in nodules with benign and Thy-3a cytology on separate occasions was not significantly different from cases with a single Thy-3a cytology. Conclusions: Thyroid nodules with Thy-3a cytology have a slightly lower risk of malignancy than Thy-3f cases. However, the difference is not significant and does not appear to be reduced by FNA on a separate occasion showing benign cytology. Management decisions for patients with Thy-3a cytology should be taken carefully to avoid missing cancers. (C) 2015 European Thyroid Association Published by S. Karger AG, Basel
引用
收藏
页码:246 / 251
页数:6
相关论文
共 50 条
  • [1] Outcome of Implementation of a Tiered Reporting System for Indeterminate Thyroid Cytology (Thy 3) into Thy 3A and Thy 3F Categories
    Mehanna, R.
    McCarthy, J.
    O'Leary, G.
    Tuthill, A.
    Murphy, M. S.
    Sheahan, P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2013, 182 : 515 - 516
  • [2] Our experience with THY3a and THY3F thyroid cytology reporting
    Di Palma, S.
    Baxendine-Jones, J.
    Pitkins, L.
    Molena, E.
    VIRCHOWS ARCHIV, 2017, 471 : S241 - S242
  • [3] Risk of malignancy in thyroid nodules with indeterminate (THY3f) cytology
    de Jong, Mc
    McNamara, J.
    Winter, L.
    Roskell, D.
    Khan, S.
    Mihai, R.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2022, 104 (09) : 703 - 709
  • [4] The incidence of thyroid cancer (TC) in patients with fine needle aspiration cytology (FNA) of Thy3a and Thy3f
    Hanna, M.
    Moradzeh, Jalal
    Morris, Alannah
    Karageorgou, Margarita
    Christakis, I.
    BRITISH JOURNAL OF SURGERY, 2020, 107 : 59 - 59
  • [5] The Final Outcome of Indeterminate Cytology (Thy3) of Thyroid Nodules in a District General Hospital over a 5 Year Period
    Doddi, S.
    Sheehan, L.
    Pizanias, M.
    Merali, N.
    Sinha, P. S.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 19 - 20
  • [6] Is conservative management of the indeterminate thyroid nodule [Thy3f or Bethesda category IV] safe?
    Gaunt, A.
    Moore, A. R.
    Huvenne, C.
    Dhami, A.
    Eades, M.
    Balasubramanian, S. P.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (12) : 5905 - 5911
  • [7] Is conservative management of the indeterminate thyroid nodule [Thy3f or Bethesda category IV] safe?
    A. Gaunt
    A. R. Moore
    C. Huvenne
    A. Dhami
    M. Eades
    S. P. Balasubramanian
    European Archives of Oto-Rhino-Laryngology, 2022, 279 : 5905 - 5911
  • [8] An evaluation of Thy3 category in thyroid cytology: a hospital based study
    Elsheikh, S.
    Khan, M.
    VIRCHOWS ARCHIV, 2014, 465 : S247 - S247
  • [9] Thy3 cytology: what to do next?
    Lakhani, Raj
    Rourke, Thomas
    Jefferis, Anthony
    Perry, Louise
    Ghiacy, Sabour
    Wood, Stephen
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2011, 93 (03) : 225 - 228
  • [10] Thy3 cytology: what to do next?
    Khan, Muhammad K.
    Moor, James
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2011, 93 (06) : 496 - 496